EDSA
HEALTHCAREEdesa Biotech Inc
$14.99-0.47 (-3.01%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving EDSA Today?
No stock-specific AI insight has been generated for EDSA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.72$20.32
$14.99
Fundamentals
Market Cap$162M
P/E Ratio—
EPS$-1.07
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin—
Debt / Equity—
Trading
Volume375K
Avg Volume (10D)—
Shares Outstanding8.9M
EDSA News
19 articles- Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock BuyingYahoo Finance·Apr 23, 2026
- Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo TreatmentYahoo Finance·Apr 20, 2026
- Edesa Biotech Invited for Oral Showcase at Respiratory Innovation SummitYahoo Finance·Mar 31, 2026
- Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 EnrollmentYahoo Finance·Mar 26, 2026
- EDSA: Strengthened Phase 3 ARDS Data Shows Significant Reduction in 28-Day MortalityYahoo Finance·Mar 2, 2026
- BC-Most Active StocksYahoo Finance·Feb 24, 2026
- Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart StudyYahoo Finance·Feb 24, 2026
- Edesa Biotech Reports Fiscal 1st Quarter 2026 ResultsYahoo Finance·Feb 13, 2026
- EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026Yahoo Finance·Dec 15, 2025
- Edesa Biotech Reports Fiscal Year 2025 ResultsYahoo Finance·Dec 12, 2025
- EDSA: EB05 Reduces Risk of Death 25% in Phase 3 ARDS Trial…Yahoo Finance·Nov 5, 2025
- Edesa Biotech Announces Upcoming Conference ScheduleYahoo Finance·Oct 31, 2025
- Edesa Biotech Reports Positive Results in Phase 3 Respiratory StudyYahoo Finance·Oct 28, 2025
- Favourable Signals For Edesa Biotech: Numerous Insiders Acquired StockYahoo Finance·Oct 28, 2025
- EDSA: EB06 Manufacturing to be Completed by End of 2025…Yahoo Finance·Aug 13, 2025
- Edesa Biotech Reports Fiscal 3rd Quarter 2025 ResultsYahoo Finance·Aug 8, 2025
- EDSA: Advancing EB06 for the Treatment of Vitiligo…Yahoo Finance·May 19, 2025
- Positive Signs As Multiple Insiders Buy Edesa Biotech StockYahoo Finance·May 18, 2025
- Edesa Biotech Reports Fiscal 2nd Quarter 2025 ResultsYahoo Finance·May 14, 2025
All 19 articles loaded
Price Data
Open$0.00
Previous Close$15.46
Day High$0.00
Day Low$0.00
52 Week High$20.32
52 Week Low$0.72
52-Week Range
$0.72$20.32
$14.99
Fundamentals
Market Cap$162M
P/E Ratio—
EPS$-1.07
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin—
Debt / Equity—
Trading
Volume375K
Avg Volume (10D)—
Shares Outstanding8.9M
About Edesa Biotech Inc
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—